Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Prostatic Neoplasms × Dosage Forms × Clear all

Phase

Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Solid Tumors 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Advanced Solid Tumors 1

Interventions

Docetaxel 39 enzalutamide 24 Prednisone 19 Abiraterone Acetate 18 Magnetic Resonance Spectroscopy 17 bicalutamide 13 Radiotherapy 13 pembrolizumab 12 abiraterone 11 Leuprolide 11 Goserelin 11 Cyclophosphamide 11 darolutamide 10 Ipilimumab 10 Specimen Handling 9 Radiosurgery 9 Radiation 9 Biopsy 9 olaparib 8 apalutamide 8 Radiotherapy, Intensity-Modulated 7 Paclitaxel 7 Injections 7 Carboplatin 7 Pluvicto 6 Cisplatin 6 sargramostim 5 radium Ra 223 dichloride 5 Nivolumab 5 Gemcitabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01784757 2021-03-17

ARAFOR

Orion Corporation, Orion Pharma

Phase 1 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡